|1.||Maze, Mervyn: 21 articles (09/2013 - 06/2002)|
|2.||Ma, Daqing: 19 articles (06/2015 - 06/2002)|
|3.||Rossaint, R: 16 articles (09/2013 - 02/2004)|
|4.||Dingley, John: 13 articles (06/2015 - 10/2003)|
|5.||Thoresen, Marianne: 12 articles (06/2015 - 02/2006)|
|6.||Franks, Nicholas P: 12 articles (01/2015 - 06/2002)|
|7.||Rossaint, Rolf: 12 articles (06/2013 - 01/2006)|
|8.||Sanders, Robert D: 11 articles (12/2012 - 08/2005)|
|9.||Sase, Shigeru: 10 articles (01/2014 - 08/2003)|
|10.||Yonas, Howard: 10 articles (01/2013 - 06/2003)|
|1.||AIDS-Related Complex (ARC)
11/01/2005 - "Performance validation of an improved Xenon-arc lamp-based CCD camera system for multispectral imaging in proteomics."
01/01/2005 - "Effect of the increase of energy density on Knoop hardness of dental composites light-cured by conventional QTH, LED and xenon plasma arc."
12/01/2002 - "Xenon plasma arc lights were introduced recently for light-cured orthodontic bonding. "
01/01/2001 - "The remaining 6 groups (3 for each adhesive) were cured with the xenon arc light for 2, 5, and 10 seconds. "
04/01/2013 - "The purpose of these clinical trials was to determine if 300 W and 150 W xenon arc solar simulators (SSs) deliver the same sun protection factor (SPF) and UVA protection factor (PFA). "
06/01/2015 - "Adding 50% xenon to 5 h delayed hypothermia significantly improved functional outcome as compared to delayed hypothermia alone despite similar reductions in brain area."
02/01/2007 - "Asynchronous administration of xenon and hypothermia at a 1 h interval produced a significant reduction in infarct volume [93 (7) vs 74 (8); P < 0.05]. "
04/01/2013 - "With promising results being reported, it is, perhaps, only a matter of time before xenon and hypothermia become established as a standard care for neonates with HIE."
06/01/2015 - "The aim of this study is to investigate whether combined hypothermia and xenon still provide neuroprotection in rats after a 5 h delay for both hypothermia and xenon. "
06/01/2015 - "During a 32-patient study randomized between hypothermia only and hypothermia with xenon, 5 neonates were given xenon during retrieval using a closed-circuit incubator-mounted system. "
06/01/2013 - "After study approval by the institutional review board, written informed consent was obtained from 30 patients with lung tumors who underwent pre- and postoperative spirometry, pulmonary perfusion SPECT and dual-energy CT (80 kV and 140 kV/Sn) after single-breath inspiration of 35 % xenon. "
08/01/2005 - "The purpose of this study was to evaluate the correlation between the TBF of pancreatic tumors calculated with xenon CT and those with perfusion CT, in order to evaluate whether perfusion CT could replace xenon CT. "
03/01/2012 - "Xenon-CT is feasible in patients with pancreatic tumors and is able to accurately estimate MVD noninvasively."
03/01/2012 - "The quantitative TBF of pancreatic tumors measured by xenon CT ranged from 22.3 to 111.4 ml/min/100 g (mean ± SD, 59.6 ± 43.9 ml/min/100 g). "
03/01/2012 - "TBFs of pancreatic tumors in 14 consecutive patients were measured by means of xenon-CT at diagnosis and following therapy. "
09/01/2014 - "5 MAC xenon preconditioning significantly improved cardiac function (P < 0.01), reduced myocardial infarct size (P < 0.01) and mitochondrial damage, increased SOD activity and decreased MDA level (P < 0.01). "
04/01/2013 - "Pretreatment with 75% xenon significantly improved cardiac function (P<0.01 vs. the I/R group, respectively), limited myocardial infarct size (20.83±2.16%, P<0.01 vs. 35.82±2.14% of the I/R group), reduced cardiac enzyme release (CK-MB, 1.00±0.19IU/L, P<0.01 vs. 0.44±0.14IU/L of the I/R group; LDH, 6.15±1.06IU/L P<0.01 vs. 3.49±0.37IU/L of the I/R group) and decreased apoptosis (6.17±0.56%, P<0.01 vs. 11.31±0.93% of the I/R group). "
11/01/2007 - "Our hypothesis for this study was that xenon reduces the size of myocardial infarction similar in extent to the reduction associated with ischemic preconditioning. "
07/01/2006 - "Several experimental studies have demonstrated a reduction in cerebral and myocardial infarction after xenon application. "
11/01/2007 - "Myocardial infarct size was not reduced with xenon preconditioning compared with the control group (59% +/- 11%, P = 0.41). "
02/03/2010 - "Our data suggested that xenon preconditioning improved histological and neurological functional outcome in both gender in a stroke model of mice."
11/01/2010 - "Prediction of stroke rehabilitation outcome with xenon-enhanced computed tomography cerebral blood flow study."
04/01/2010 - "This has led to the general thinking that clinical trials with xenon could be initiated in acute stroke patients in a next future. "
03/31/2009 - "CBF = cerebral blood flow; DBP = diastolic blood pressure; DEFUSE = Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution; DWI = diffusion-weighted imaging; EPITHET = Echoplanar Imaging Thrombolytic Evaluation Trial; FOV = field of view; ICA = internal carotid artery; IQR = interquartile range; MCA = middle cerebral artery; MTT = mean transit time; NIHSS = NIH Stroke Scale; PWI = perfusion-weighted imaging; PWI-MRI = magnetic resonance perfusion-weighted imaging; ROC = receiver operating characteristic; ROI = region of interest; SBP = systolic blood pressure; SVD = singular value decomposition; Xe-CT = xenon CT."
10/01/2006 - "Twenty-three patients who underwent quantitative CBF assessment with Xenon CT studies for acute stroke before intra-arterial (IA) thrombolysis for a middle cerebral artery (MCA) or internal carotid artery terminus occlusion within 6 hours of symptom onset were studied. "
|6.||Noble Gases (Rare Gases)
|7.||glucuronyl glucosamine glycan sulfate (Vessel)
|9.||Nitrous Oxide (Laughing Gas)